Therapeutic significance of quinolines: a patent review (2013-2015)

References

• Yan R, Liu X, Pan C, et al. Aerobic synthesis of substituted quinoline from aldehyde and aniline: copper-catalyzed intermolecular C–H active and C–C formative cyclization. Org Lett. 2013;15(18):4876–4879.
   PubMed Web of Science ®Google Scholar
• Chung P-Y, Bian Z-X, Pun H-Y, et al. Recent advances in research of natural and synthetic bioactive quinolines. Future Med Chem. 2015;7(7):947–967.
   PubMed Web of Science ®Google Scholar
• Rehan M, Hazra G, Ghorai P. Synthesis of polysubstituted quinolines via transition-metal-free oxidative cycloisomerization of o-cinnamylanilines. Org Lett. 2015;17(7):1668–1671.
   PubMed Web of Science ®Google Scholar
• Zhang J, Yang PL, Gray NS. Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer. 2009;9(1):28–39.
   PubMed Web of Science ®Google Scholar
• Davis IJ, McFadden AW, Zhang YX, et al. Identification of the receptor tyrosine kinase c-met and its ligand, hepatocyte growth factor, as therapeutic targets in clear cell sarcoma. Cancer Res. 2010;70(2):639–645.
   PubMed Web of Science ®Google Scholar
• Gong P, Zhao Y, Liu Y, et al., inventors; Shenyang Pharmaceutical University, Peop. Rep. China. assignee. Preparation of pyrazolone containing quinoline compounds as c-Met kinase inhibitor for the treatment of c-Met overexpressed cancer patent. CN105017217A. 2015.
   Google Scholar
• Gong P, Zhao Y, Liu Y, et al., inventors; Shenyang Pharmaceutical University, Peop. Rep. China. assignee. Quinoline derivatives as c-Met kinase inhibitors and their preparation and use for the treatment of c-Met kinase-mediated diseases patent. US20150307453A1. 2015.
   Google Scholar
• Gong P, Zhao Y, Liu Y, et al., inventors; Shenyang Pharmaceutical University, Peop. Rep. China. assignee. Preparation of quinoline compounds for preventing and/or treating c-Met kinase abnormal over-expression induced diseases patent. WO2014067417A1. 2014.
   Google Scholar
• Gong P, Zhao Y, Liu Y, et al., inventors; Shenyang Pharmaceutical University, Peop. Rep. China. assignee. Preparation of quinoline compounds for preventing and/or treating c-Met kinase abnormal over-expression induced diseases patent. CN102977014A. 2013.
   Google Scholar
• Gong P, Zhao Y, Liu Y, et al., inventors; Shenyang Pharmaceutical University, Peop. Rep. China. assignee. 1,2,3-Triazole-containing quinoline compound useful in treatment of diseases caused by c-Met kinase abnormally high expression and its preparation patent. CN104119317A. 2014.
   Google Scholar
• Gong P, Liu Y, Zhao Y, et al., inventors; Shenyang Pharmaceutical University, Peop. Rep. China. assignee. Preparation of 4-substituted quinoline compounds as c-met kinase inhibitors patent. CN104086530A. 2014.
   Google Scholar
• Gong P, Zhao Y, Liu Y, et al., inventors; Shenyang Pharmaceutical University, Peop. Rep. China. assignee. Preparation of quinoline derivatives for treating and/or preventing cancer patent. CN104072480A. 2014.
   Google Scholar
• Gong P, Liu Y, Zhao Y, et al., inventors; Shenyang Pharmaceutical University, Peop. Rep. China. assignee. Preparation of 2-aryl-substituted quinoline compounds for treatment of cancer patent. CN103965107A. 2014.
   Google Scholar
• Gong P, Zhao Y, Liu Y, et al., inventors; Shenyang Pharmaceutical University, Peop. Rep. China; Benxi Pharmaceutical Science and Technology Co., Ltd., Shenyang Pharmaceutical University. assignee. Preparation of hexahydropyrimidone containing quinoline compounds as c-Met kinase inhibitors patent. CN103709145A. 2014.
   Google Scholar
• Chen C, inventor Tianjin Longbogen Pharmaceutical Co., Ltd., Peop. Rep. China. assignee. Preparation of quinoline derivatives for treating solid tumor and leukemia patent. CN104211686A. 2014.
   Google Scholar
• Xu H, inventor Wuhan Shengyun Biopharma Co., Ltd., Peop. Rep. China. assignee. Preparation of quinoline compounds containing 1,2,4-triazine-dione and use as c-Met kinase inhibitors for treating proliferative diseases patent. US20130252958A1. 2013.
   Google Scholar
• Yu J, Guo L, Zhao F, et al., inventors; Shanghai Pharmaceuticals Holding Co., Ltd., Peop. Rep. China. assignee. Quinoline-series compound, its preparation method, and pharmaceutical application patent. CN104109166A. 2014.
   Google Scholar
• Liu P, Cheng H, Roberts TM, et al. Targeting the phosphoinositide 3-kinase (PI3K) pathway in cancer. Nat Rev Drug Discov. 2009;8(8):627–644.
   PubMed Web of Science ®Google Scholar
• Hu Y, Lv X, Dong X, inventors; Zhejiang University, Peop. Rep. China. assignee. Preparation of 3,4-disubstituted-6-(3-pyridyl)quinoline derivatives as PI3Kα inhibitors patent. CN105130954A. 2015.
   Google Scholar
• Hu Y, Lv X, Dong X, inventors; Zhejiang University, Peop. Rep. China. assignee. 4-α,β-Unsaturated-sulfonylamino-quinolines as PI3Kα inhibitors and their preparation, pharmaceutical compositions and use in the treatment of cancer patent. CN104961725A. 2015.
   Google Scholar
• Cheng J, Qin J, inventors; Shanghai Huilun Life Science & Technology Co., Ltd., Peop. Rep. China. assignee. Preparation of morpholino-quinoline compounds for the treatment of diseases associated with PI3K/mTOR patent. CN103936762A. 2014.
   Google Scholar
• Zhu J, Song Y, Han J, et al., inventors; The Second Military Medical University, PLA, Peop. Rep. China. assignee. Preparation of N-(5-(quinolin-6-yl)pyridin-3-yl) benzenesulfamide derivatives for treating tumor and immune disease patent. CN103788071A. 2014.
   Google Scholar
• Zhu J, Song Y, Han J, et al., inventors; Second Military Medical University, PLA, Peop. Rep. China. assignee. Preparation of N-(5-(quinolin-6-yl)pyridin-3-yl) benzenesulfamide derivatives for treating tumor and immune disease patent. WO2014067473A1. 2014.
   Google Scholar
• Li X, Dong Q, Chen Y, et al., inventors; Shanghai Hengrui Pharmaceutical Co., Ltd., Peop. Rep. China; Jiangsu Hengrui Medicine Co., Ltd. assignee. Imidazo quinoline derivative as mTOR and PI3K-kinase inhibitor useful in the treatment of various diseases, and its preparation patent. WO2013053273A1. 2013.
   Google Scholar
• Li X, Dong Q, Chen Y, et al., inventors; Shanghai Hengrui Pharmaceutical Co., Ltd., Peop. Rep. China; Jiangsu Hengrui Medicine Co., Ltd. assignee. Imidazo quinoline derivative as mTOR and PI3K-kinase inhibitor useful in the treatment of various diseases, and its preparation patent. CN103030637A. 2013.
   Google Scholar
• Kumar S, Sharma R, Deore VB, et al., inventors; Piramal Enterprises Limited, India. assignee. Preparation of imidazo[4,5-c]quinoline derivatives that are kinase inhibitors useful in treatment of proliferative, neoplastic and other kinase-mediated diseases patent. WO2014141118A1. 2014.
   Google Scholar
• Reddy EP, Reddy MVR, inventors; Temple University - of the Commonwealth System of Higher Education, USA. assignee. Preparation of 3-aminothieno[3,2-c]quinoline derivatives as antitumor agents patent. WO2013142010A1. 2013.
   Google Scholar
• Wan H, Shen J, Li C, et al., inventors; Shanghai Pharmaceuticals Holding Co., Ltd., Peop. Rep. China. assignee. Deuterated 3-cyanoquinoline compounds as protein kinase inhibitors and their preparation, pharmaceutical compositions and use in the treatment of cancer patent. WO2014086284A1. 2014.
   Google Scholar
• Zhang D, inventor USA. assignee. Substituted quinolines as Bruton’s tyrosine kinases inhibitors patent. WO2013152135A1. 2013.
   Google Scholar
• Lv H, Chen Y, Wang S, et al., inventors; Shanghai Hengrui Pharmaceutical Co., Ltd., Peop. Rep. China; Jiangsu Hengrui Medicine Co., Ltd. assignee. Preparation of quinoline derivatives protein kinase inhibitors patent. CN103382206A. 2013.
   Google Scholar
• Bock MG, Moebitz H, Panigrahi SK, et al., inventors; Novartis AG, Switz. assignee. Preparation of 1-(cyclohexyl)-8-(phenyl)-1H-imidazo[4,5-c]quinoline derivatives as MEK kinase inhibitors useful in the treatment of cancer and inflammation patent. WO2015022664A1. 2015.
   Google Scholar
• Schadt O, Esdar C, Schultz-Fademrecht C, et al., inventors; Merck Patent GmbH, Germany. assignee. Preparation of a quinoline inhibitor of the macrophage stimulating 1 receptor patent. WO2014194975A1. 2014.
   Google Scholar
• Li Y-L, Burns DM, Feng H, et al., inventors; Incyte Corporation, USA. assignee. Preparation of bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors for treating proliferative and immune disorders patent. WO2014110574A1. 2014.
   Google Scholar
• Chand P, Tapolsky GH, inventors; Advanced Cancer Therapeutics, LLC, USA. assignee. Preparation of pyridynyltrifluoromethylquinolinylpropenone derivatives for use as a PFKFB3 inhibitors patent. WO2013148228A1. 2013.
   Google Scholar
• Larsen AK, Ouaret D, El Ouadrani K, et al. Targeting EGFR and VEGF(R) pathway cross-talk in tumor survival and angiogenesis. Pharmacol Ther. 2011;131(1):80–90.
   PubMed Web of Science ®Google Scholar
• Zhu K, Mao C, Qin L, inventors; Nanjing Zhongruiyuan Biotechnology Co., Ltd., Peop. Rep. China. assignee. Preparation of alkynyl-substituted quinoline derivatives as antitumor agents patent. CN104817497A. 2015.
   Google Scholar
• Ong WZ, Nowak PW, Askew BC, et al., inventors; Kala Pharmaceuticals, Inc., USA. assignee. Preparation of quinoline and quinazoline derivatives useful in treating and/or preventing diseases patent. WO2014127214A1. 2014.
   Google Scholar
• Chen Y, Guo S, inventors; Hinova Pharmaceuticals Inc., Peop. Rep. China. assignee. Preparation of N-[2-chloro-4-(4-quinolinyloxy)phenyl]-N’-(3-isoxazolyl)urea derivatives as antitumor agents patent. CN104693196A. 2015.
   Google Scholar
• Shanghai Renli Pharmaceutical Science & Technology Co., Ltd., Peop. Rep. China. assignee. Quinoline derivatives as a VEGFR inhibitor useful in treatment of cancer and their preparation patent. CN103524409A. 2014.
   Google Scholar
• Xia G, Yu Y, Chen W, et al., inventors; Shanghai Pharmaceuticals Holding Co., Ltd., Peop. Rep. China; Zhejiang University. assignee. Preparation of quinoline and quinazoline derivatives as antitumor agents patent. CN103965120A. 2014.
   Google Scholar
• Ntranos A, Casaccia P. Bromodomains: translating the words of lysine acetylation into myelin injury and repair. Neurosci Lett. 2016;623:4–10.
   Web of Science ®Google Scholar
• Sharma R, Kulkarni S, Kulkarni M, et al., inventors; Piramal Enterprises Limited, India. assignee. Preparation of imidazoquinoline compounds as bromodomain inhibitors patent. WO2015049629A1. 2015.
   Google Scholar
• Sasmal S, Hosahalli S, inventors; Aurigene Discovery Technologies Limited, India. assignee. Preparation of substituted imidazo[4,5-c]quinoline derivatives as bromodomain inhibitors patent. WO2014128655A1. 2014.
   Google Scholar
• Demont EH, Jones KL, Watson RJ, inventors; GlaxoSmithKline LLC, USA. assignee. Preparation of 4-(8-methoxy-1-(1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1H-imidazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazole, its salts and isomers and their use as bromodomain inhibitors patent. WO2013024104A1. 2013.
   Google Scholar
• Amans D, Atkinson SJ, Harrison LA, et al., inventors; GlaxoSmithKline Intellectual Property No.2 Limited, UK. assignee. Preparation of acylaminotetrahydroquinoline derivatives for use as bromodomain inhibitors patent. WO2014140076A1. 2014.
   Google Scholar
• Babaoglu K, Corkey BK, Jiang RH, et al., inventors; Gilead Sciences, Inc., USA. assignee. prepn. of quinoline derivs. as bromodomain inhibitors useful for treatment of solid tumors and lymphoma patent. US20150148344A1. 2015.
   Google Scholar
• Falkenberg KJ, Johnstone RW. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat Rev Drug Discov. 2014;13(9):673–691.
   PubMed Web of Science ®Google Scholar
• Yun Z, Wang H, inventors; Guangzhou Esa Biotech Co., Ltd, Peop. Rep. China. assignee. Quinoline-hydroxamic acid derivatives as protein kinase and histone deacetylase inhibitors and their preparation, pharmaceutical compositions and use in the treatment of diseases patent. WO2013040801A1. 2013.
   Google Scholar
• Fang H, Wang L, Yang X, et al., inventors; Shandong University, Peop. Rep. China. assignee. Substituted quinoline histone deacetylase (HDAC) inhibitor and preparation method and application thereof in preparation of drug for preventing or treating mammal disease caused by HDAC abnormal expression patent. CN104592114A. 2015.
   Google Scholar
• Deng W, Liu J, An N, et al., inventors; East China University of Science and Technology, Peop. Rep. China. assignee. Pyrazoloquinoline compounds as histone deacetylase inhibitors and their preparation, pharmaceutical compositions and use in the treatment of cancers patent. CN102977095A. 2013.
   Google Scholar
• Zhang L, Song Y, Qi Y, et al., inventors; The Second Military Medical University, PLA, Peop. Rep. China. assignee. Preparation of quinoline derivatives as histone deacetylase inhibitors patent. CN104926726A. 2015.
   Google Scholar
• Hoves S, Kuhn B, Ricklin F, et al., inventors; Hoffmann-La Roche Inc., USA. assignee. Preparation of 4-amino-imidazoquinoline compounds as TLR agonists patent. US20150299194A1. 2015.
   Google Scholar
• Huang H-S, Chen T-C, Chen S-J, et al., inventors; National Defense Medical Center, Taiwan. assignee. Preparation of novel indeno[1,2-c]quinolin-11-one derivatives as antitumor agents patent. US20150197492A1. 2015.
   Google Scholar
• Heisler I, Mueller T, Siebeneicher H, et al., inventors; Bayer Pharma Aktiengesellschaft, Germany. assignee. N-Pyrazolyl quinolinecarboxamides as glucose transport inhibitors and their preparation patent. WO2015091428A1. 2015.
   Google Scholar
• Faernegaardh K, Gravenfors Y, Ernfors P, et al., inventors; Glionova AB, Swed. assignee. 2,4-Disubstituted quinoline derivatives and their preparation and use for the treatment of cancer patent. WO2015033228A2. 2015.
   Google Scholar
• Inukai T, Takeuchi J, Yasuhiro T, inventors; Ono Pharmaceutical Co., Ltd., Japan. assignee. Preparation of quinolinecarboxamide compounds, their medical compositions, and preventive and/or therapeutic method for Axl-related disorders patent. WO2015012298A1. 2015.
   Google Scholar
• Wang S, Cao X, Cao C, et al., inventors; Jiangsu Tangguo Pharmaceutical Technology Co., Ltd., Peop. Rep. China. assignee. Preparation of 3-cyano-4-(arylamino)quinoline derivatives as HDM2 and HDMX dual inhibitors useful in the treatment of cancer patent. CN103804292A. 2014.
   Google Scholar
• Zhou H-J, Wustrow D, inventors; Cleave Biosciences, Inc., USA. assignee. Preparation of quinolines and quinazolines and their compositions and methods for JAMM protein inhibition patent. WO2014066506A2. 2014.
   Google Scholar
• Brown KK, Chai D, Dodson CS, et al., inventors; GlaxoSmithKline LLC, USA. assignee. Preparation of quinoline derivatives as inhibitors of lactate dehydrogenase a useful in the treatment of cancer patent. WO2013096153A1. 2013.
   Google Scholar
• Brown KK, Chai D, Dodson CS, et al., inventors; GlaxoSmithKline LLC, USA. assignee. Preparation of quinoline derivatives as inhibitors of lactate dehydrogenase a useful in the treatment of cancer patent. WO2013096151A1. 2013.
   Google Scholar
• Ceccarelli SM, Conte A, Kuehne H, et al., inventors; F. Hoffmann-La Roche AG, Switz. assignee. Preparation of arylquinoline derivatives as dual FABP inhibitors patent. WO2013064465A1. 2013.
   Google Scholar
• Chabot G, Giorgi-Renault S, Desbene-Finck S, et al., inventors; Centre National de la Recherche Scientifique CNRS, Fr.; Universite Paris Descartes; Institut National de la Sante et de la Recherche Medicale Inserm; Ecole Nationale Superieure de Chimie de Paris. assignee. Preparation of water soluble 4-azapodophyllotoxin analogs as medicaments for the treatment of cancer patent. WO2015107119A1. 2015.
   Google Scholar
• Zhu H, Tao X, Duan Y, et al., inventors; Nanjing University, Peop. Rep. China. assignee. Preparation of quinoline imidazole derivatives for inhibiting telomerase activity patent. CN104402864A. 2015.
   Google Scholar
• Huang Z, Gu L, Du G, et al., inventors; Sun Yat-Sen University, Peop. Rep. China. assignee. Preparation of peptide-substituted coumarone quinoline derivatives as antitumor agents patent. CN104017047A. 2014.
   Google Scholar
• Huang Z, Gu L, Du G, et al., inventors; Sun Yat-Sen University, Peop. Rep. China. assignee. Preparation of methylbenzofuran quinoline derivatives as antitumor agents patent. CN103382207A. 2013.
   Google Scholar
• Sidoryk K, Kaczmarska M, Bujak I, et al., inventors; Instytut Farmaceutyczny, Pol. assignee. Preparation of 5H-indolo[2,3-b]quinoline compounds as cytotoxic agents for treatment of neoplastic diseases patent. WO2015147666A1. 2015.
   Google Scholar
• Iguchi T, El Sayed IET, Sasaki K, et al., inventors; Okayama University, Japan. assignee. Indoloquinoline derivative as antimalarial/anticancer agent and method for the preparation thereof patent. JP2013107869A. 2013.
   Google Scholar
• Iguchi T, Wang N, Imai T, et al., inventors; Okayama University, Japan. assignee. Preparation of indolo[3,2-c]quinoline derivatives as antimalarial and anticancer agents patent. JP2015063476A. 2015.
   Google Scholar
• Gakh AA, Krasavin M, Karapetian R, et al., inventors; United States Dept. of Energy, USA. assignee. Preparation of anti-cancer agents based on N-acyl-2,3-dihydro-1H-pyrrolo[2,3-b]quinoline derivatives patent. US8420815B1. 2013.
   Google Scholar
• Yong J, Lu C, inventors; Fujian Institute of Research on the Structure of Matter, CAS, Peop. Rep. China. assignee. Preparation of quinoline derivatives and their application as anticancer agents patent. CN104230912A. 2014.
   Google Scholar
• Courcambeck J, Bassissi F, Brun S, et al., inventors; Genoscience Pharma, Fr. assignee. Preparation of arylquinolines as anticancer agents patent. WO2014147611A1. 2014.
   Google Scholar
• Ji M, Cai J, Zhang S, et al., inventors; Southeast University, Peop. Rep. China. assignee. Quinoline derivatives as antitumor agents and their preparation, pharmaceutical compositions and use in the treatment of cancer patent. CN103772353A. 2014.
   Google Scholar
• Lee H, Solomon VR, Pundir S, inventors; Advanced Medical Research Institute of Canada, Can. assignee. Preparation of quinoline sulfonyl derivatives for the treatment of cancer patent. WO2014134705A1. 2014.
   Google Scholar
• Shi L, Xue J, Wu T, et al., inventors; China Pharmaceutical University, Peop. Rep. China. assignee. Quinoline-4-amine derivatives containing benzimidazole structure and its preparation method and application in preparing antitumor drug patent. CN103709146A. 2014.
   Google Scholar
• Tang Y, Wang L, Xiang J, inventors; Institute of Chemistry, Chinese Academy of Sciences, Peop. Rep. China. assignee. 2,2ʹ-bipyridine-6,6ʹ-diformyl-quinoline-2-amine derivatives, their preparation method and application as antitumor agents patent. CN103601719A. 2014.
   Google Scholar
• Kamal A, Hussaini SMA, Sucharitha ML, et al. Synthesis and antimicrobial potential of nitrofuran-triazole congeners. Org Biomol Chem. 2015;13(36):9388–9397.
   PubMed Web of Science ®Google Scholar
• Shen Y, Tang J, Liang X, et al., inventors; Shaoxing University, Peop. Rep. China. assignee. Preparation of tetrahydropyrrolo[3,4-c]quinoline-1,3-dione derivatives as antibacterial agents patent. CN104974152A. 2015.
   Google Scholar
• Alapati C, Banerjee A, Rangarajan R, et al., inventors; Vitas Pharma Research Pvt Ltd., India. assignee. Preparation of heterocyclic compounds as inhibitors of DNA gyrase for the treatment of bacterial infections patent. WO2014057415A2. 2014.
   Google Scholar
• Egan SM, inventor The University of Kansas, USA. assignee. Inhibiting microbial infections with quinoline compounds patent. US20140088144A1. 2014.
   Google Scholar
• Guillemont JEG, Motte MMS, Lancois DFA, et al., inventors; Janssen Pharmaceutica NV, Belg. assignee. Preparation of antibacterial quinoline derivatives patent. WO2013160431A1. 2013.
   Google Scholar
• Guillemont JEG, Motte MMS, Lancois DFA, et al., inventors; Janssen Pharmaceutica NV, Belg. assignee. Preparation of quinoline derivatives useful as antibacterials patent. WO2013160435A1. 2013.
   Google Scholar
• Sun X, He X, Wen X, et al., inventors; Heilongjiang Bayi Agricultural University, Peop. Rep. China. assignee. 4,5-Dihydroimidazolo[1,2-a]quinoline derivative useful in the treatment of bacterial infection and its preparation patent. CN102898425A. 2013.
   Google Scholar
• Taylor RK, Gribble GW, inventors; Trustees of Dartmouth College, USA. assignee. Preparation of bis-quinoline derivatives as type 4 prepilin peptidase inhibitors and methods of using them as antibacterial agents patent. WO2015123130A1. 2015.
   Google Scholar
• Deng J, Lei H, Wang W, et al., inventors; Chongqing Pharmaceutical Research Institute Co., Ltd., Peop. Rep. China. assignee. Preparation of quinoline derivatives as antitubercular agents patent. CN103664877A. 2014.
   Google Scholar
• Deng J, Lei H, Wang W, et al., inventors; Chongqing Pharmaceutical Research Institute Co., Ltd., Peop. Rep. China. assignee. Preparation of quinoline derivatives as antitubercular agents patent. WO2015096611A1. 2015.
   Google Scholar
• Nazarenko AB, Fedorov VE, Il’in VI, et al., inventors; ZAO “Pharm-Sintez”, Russia. assignee. Quinoline derivatives, in particular 5,6,7-substituted 1-(2-chloroquinolin-3-yl)-4-dimethylamino-2-(naphthalen-1-yl)-1-phenylbutan-2-ols, method for producing same and use of said compounds patent. WO2013039428A2. 2013.
   Google Scholar
• Zhu Q, Zhang T, Liu L, et al., inventors; Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Peop. Rep. China. assignee. Preparation of indole[3,2-c]quinolines as tuberculostatics patent. CN103554103A. 2014.
   Google Scholar
• Yang Z, inventor Ruian Puluo Biotechnology Co., Ltd., Peop. Rep. China. assignee. 3-Fluoro-4-(5-(4-methylpiperazine-1-yl)-3,4-dihydro quinoline-1(2H)-yl) benzamides useful in treatment of fungal infection and their preparation patent. CN104230801A. 2014.
   Google Scholar
• Higuchi T, Kato N, Umezawa N, inventors; Public University Corporation Nagoya City University, Japan. assignee. Preparation of quinoline derivatives as antimalarial agents patent. WO2015133280A1. 2015.
   Google Scholar
• Gilbert IH, Norcross N, Baragana Ruibal B, et al., inventors; University of Dundee, UK. assignee. Preparation of quinoline-4-carboxamides as antimalarial agents patent. WO2013153357A1. 2013.
   Google Scholar
• Crusz SM, Balkwill FR. Inflammation and cancer: advances and new agents. Nat Rev Clin Oncol. 2015;12(10):584–596.
   PubMed Web of Science ®Google Scholar
• Leonard KA, Barbay K, Edwards JP, et al., inventors; Janssen Pharmaceutica NV, Belg. assignee. Preparation of quinolinyl secondary alcohols as modulators of retinoic acid-related nuclear receptor gamma t (RORγt) patent. WO2015057206A1. 2015.
   Google Scholar
• Leonard KA, Barbay K, Edwards JP, et al., inventors; Janssen Pharmaceutica N.V., Belg. assignee. Preparation of 3-benzylquinoline and 3-heterocyclylmethylquinoline derivatives as modulators of retinoic acid-related nuclear receptor gamma t (RORγt) patent. US20150105366A1. 2015.
   Google Scholar
• Leonard KA, Barbay K, Edwards JP, et al., inventors; Janssen Pharmaceutica N.V., Belg. assignee. Preparation of heteroaryl linked quinoline derivatives as modulators of retinoic acid-related nuclear receptor gamma t (RORγt) patent. US20150105365A1. 2015.
   Google Scholar
• Leonard KA, Barbay K, Edwards JP, et al., inventors; Janssen Pharmaceutica N.V., Belg. assignee. Preparation of phenylquinoline derivatives as modulators of retinoic acid-related nuclear receptor gamma t (RORγt) patent. US20150105404A1. 2015.
   Google Scholar
• Leonard KA, Barbay K, Edwards JP, et al., inventors; Janssen Pharmaceutica NV, Belg. assignee. Preparation of alkylquinoline derivatives as modulators of retinoic acid-related nuclear receptor gamma t (RORγt) patent. US20150105369A1. 2015.
   Google Scholar
• Leonard KA, Barbay K, Edwards JP, et al., inventors; Janssen Pharmaceutica NV, Belg. assignee. Preparation of heteroaryl linked quinolinyl modulators of RORγt patent. US20140107097A1. 2014.
   Google Scholar
• Leonard KA, Barbay K, Edwards JP, et al., inventors; Janssen Pharmaceutica NV, Belg. assignee. Preparation of methylene linked quinolinyl modulators of RORγt patent. US20140107094A1. 2014.
   Google Scholar
• Leonard KA, Barbay K, Edwards JP, et al., inventors; Janssen Pharmaceutica NV, Belg. assignee. Preparation of heteroaryl linked quinolinyl as modulators of RORγt patent. US20140107096A1. 2014.
   Google Scholar
• Huang C, Bai C, inventors; Sun Yat-Sen University, Peop. Rep. China. assignee. Application of quinoline-sulfonamide compounds as Th17 cell differentiation inhibitor patent. CN105147686A. 2015.
   Google Scholar
• Gaweco A, Tilley JW, Walker J, et al., inventors; USA. assignee. Preparation of quinoline compounds as ROR (retinoid-related orphan receptor) modulators and their therapeutic uses patent. WO2013159095A1. 2013.
   Google Scholar
• Hoffmann M, Bischoff D, Dahmann G, et al., inventors; Boehringer Ingelheim International GmbH, Germany. assignee. Preparation of substituted quinolines as Syk inhibitors for therapy patent. WO2013014060A1. 2013.
   Google Scholar
• Anderson DR, Bunnage ME, Curran KJ, et al., inventors; Pfizer Inc., USA. assignee. Bicyclic-fused heteroaryl or aryl compounds as IRAK4 inhibitors and their preparation patent. WO2015150995A1. 2015.
   Google Scholar
• Takemura S, Miyake Y, Kouketsu A, et al., inventors; Kowa Company, Ltd., Japan. assignee. Preparation of quinoline derivative having TLR inhibitory activity patent. WO2014034719A1. 2014.
   Google Scholar
• Abeywardane A, Broadwater J, Takahashi H, inventors; Boehringer Ingelheim International GmbH, Germany. assignee. Preparation of pyrazolylpyridinylquinolines as inhibitors of leukotriene production for treatment of cardiovascular, inflammatory and other diseases patent. US20150018333A1. 2015.
   Google Scholar
• Abeywardane A, Broadwater J, Brunette SR, et al., inventors; Boehringer Ingelheim International GmbH, Germany. assignee. Preparation of pyrazolylpyridinyl quinolines and similar compds. as leukotriene prodn. inhibitors for treatment of cardiovascular, inflammatory and other diseases patent. US20150018334A1. 2015.
   Google Scholar
• Cai Z, inventor Foshan Saiweisi Pharmaceutical Technology Co., Ltd., Peop. Rep. China. assignee. Preparation of quinoline derivatives containing nitrophenyl group as glucokinase activator useful for the treatment of type-II diabetes patent. CN104592112A. 2015.
   Google Scholar
• Cai Z, inventor Foshan Saiweisi Pharmaceutical Technology Co., Ltd., Peop. Rep. China. assignee. Preparation of quinoline derivatives containing cyanophenyl group as glucokinase activator useful for the treatment of type-II diabetes patent. CN104592113A. 2015.
   Google Scholar
• Cai Z, inventor Foshan Saiweisi Pharmaceutical Technology Co., Ltd., Peop. Rep. China. assignee. Preparation of alkoxy substituted quinoline derivatives as glucokinase activator useful for the treatment of type-II diabetes patent. CN104557697A. 2015.
   Google Scholar
• Cai Z, inventor Foshan Saiweisi Pharmaceutical Technology Co., Ltd., Peop. Rep. China. assignee. preparation of quinoline containing glucokinase activators for treatment of type 2 diabetes patent. CN104557695A. 2015.
   Google Scholar
• Cai Z, inventor Foshan Saiweisi Pharmaceutical Technology Co., Ltd., Peop. Rep. China. assignee. Preparation of quinoline containing glucokinase activator for treating type 2 diabetes patent. CN104672133A. 2015.
   Google Scholar
• Babaoglu K, McFadden R, Mitchell ML, inventors; Gilead Sciences, Inc., USA. assignee. Preparation of quinoline derivatives useful in treatment of HIV infection patent. WO2015179448A1. 2015.
   Google Scholar
• Old DW, inventor Allergan, Inc., USA. assignee. Preparation of alkyl or hydroxyalkyl-1-naphthamide or quinoline derivatives useful in treatment of glaucoma and ocular hypertension patent. US20150175586A1. 2015.
   Google Scholar
• Gu J, Zhu H, Kuang Y, et al., inventors; General Hospital of Chengdu Military Region of PLA, Peop. Rep. China. assignee. Preparation of quinoline-4-carboxamide derivatives and their medicinal use for treating posttraumatic stress disorder patent. CN104710358A. 2015.
   Google Scholar
• Basinger J, Breitenbucher J, Freestone G, et al., inventors; Dart NeuroScience, LLC, USA. assignee. Preparation of substituted naphthyridine and quinoline compounds as MAO inhibitors patent. US20140275548A1. 2014.
   Google Scholar
• Esteban G, Unzeta M, Inokuchi T, et al., inventors; Universitat Autonoma de Barcelona, Spain; Consejo Superior de Investigaciones Cientificas; National University Corporation Okayama University; Universidad de Alcala. assignee. Preparation of quinoline derivatives as neuroprotective multi-target directed drugs patent. EP2727916A1. 2014.
   Google Scholar
• Hadida-Ruah SS, Anderson C, Arumugam V, et al., inventors; Vertex Pharmaceuticals Incorporated, USA. assignee. Preparation of quinoline and quinazoline amides as modulators of sodium channels patent. WO2014120815A1. 2014.
   Google Scholar